Literature DB >> 15370944

Methamphetamine abstinence syndrome: preliminary findings.

Thomas F Newton1, Ari D Kalechstein, Sonia Duran, Nicolette Vansluis, Walter Ling.   

Abstract

Retrospective reports suggest that chronic use of methamphetamine is associated with a prolonged abstinence syndrome; however, there are no prospective studies confirming this. Nineteen non-treatment-seeking methamphetamine-dependent volunteers participated in a study of mood during initial abstinence. Moderate levels of depression were reported during the first several days of abstinence, with minimal levels reported thereafter. The most prominent symptoms were anhedonia, irritability, and poor concentration. The abstinence syndrome associated with methamphetamine dependence varied considerably in intensity and duration but generally was mild and resolved quickly for most individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370944     DOI: 10.1080/10550490490459915

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  53 in total

Review 1.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

2.  Anhedonia associated with stimulant use and dependence in a population-based sample of American adults.

Authors:  Adam M Leventhal; Molly Brightman; Katherine J Ameringer; Jodie Greenberg; Lavonda Mickens; Lara A Ray; Ping Sun; Steve Sussman
Journal:  Exp Clin Psychopharmacol       Date:  2010-12       Impact factor: 3.157

3.  Differences in cortical activity between methamphetamine-dependent and healthy individuals performing a facial affect matching task.

Authors:  Doris E Payer; Matthew D Lieberman; John R Monterosso; Jiansong Xu; Timothy W Fong; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2007-10-26       Impact factor: 4.492

Review 4.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

Review 5.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

Review 6.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

7.  The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting.

Authors:  Richard A Rawson; Joy Chudzynski; Rachel Gonzales; Larissa Mooney; Daniel Dickerson; Alfonso Ang; Brett Dolezal; Christopher B Cooper
Journal:  J Subst Abuse Treat       Date:  2015-04-15

Review 8.  Methamphetamine and the risk of pulmonary arterial hypertension.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Curr Opin Pulm Med       Date:  2018-09       Impact factor: 3.155

9.  A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine.

Authors:  Matthew J Mimiaga; Sari L Reisner; David W Pantalone; Conall O'Cleirigh; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2012-10-03       Impact factor: 5.078

10.  Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse.

Authors:  Thomas F Newton; Richard De La Garza; Ari D Kalechstein; Desey Tziortzis; Caitlin A Jacobsen
Journal:  Am J Addict       Date:  2009 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.